Serum GDF-15 and LGALS3BP as Prognostic Biomarkers in Sepsis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to find out whether blood levels of two proteins, GDF-15 and LGALS3BP, measured at intensive care unit admission and at 72 hours, can help predict survival and organ dysfunction in adult patients with sepsis or septic shock. Blood samples are collected together with routine laboratory tests, without additional needle sticks. The study does not change patient treatment.
Epistemonikos ID: 9f82ac757e7ef52c7a5d452030199f91d57afe59
First added on: Oct 31, 2026